Artificial Blood Market: By Product Type, By Application, By Distribution Channel, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Artificial Blood Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Hemoglobin-Based Oxygen Carriers, Perflurocarbon-Based Products, Recombinant Factors, Synthetic Platelets, Plasma Expanders, Others), By Application (Traumatic Injuries, Blood Disorders, Anemia, Surgeries, Others), By Distribution Channel(Hospitals, Clinics, Blood Banks), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

Artificial Blood Market size was valued at US$ 3,537.5 million in 2024 and is expected to reach US$ 7,771.5 million by 2031, growing at a significant CAGR of 11.90% from 2025-2031. Artificial blood or synthetic blood and blood products are the alternatives to blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in traumatic injuries and other disease conditions for the transportation of carbon dioxide and oxygen across the body. Moreover, scientists are focusing on the development of artificial blood due to an inadequate number of blood donors leads to a shortage of blood.

However, there are adverse effects associated with artificial blood such as hemoglobin-based blood substitutes might increase the occurrence of heart attacks. Artificial blood is mostly utilized in the treatment of trauma patients, therefore an increase in the number of people suffering from heart and renal diseases is expected to drive market growth over the forecast period. Conventional blood transfusion methods are frequently impractical to provide in battlefield circumstances. Artificial blood, which is a simple technique to manage blood supply in an effective and time-saving manner, might assist medical care in the armed forces in that event. All of these factors are contributing to the global growth of the artificial blood market.

Key Developments

  • In April 2017, Plasticell collaborated with Kings College London to progress the preclinical trials of artificial blood platelet products, prepared from pluripotent stem cells

summary download arrow Download Sample

Artificial Blood Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

11.9%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Artificial Blood Market Dynamics

Drivers: Increase in the prevalence of anemia and traumatic injuries, Rise in R&D for the innovation of newer products, Growing number of surgeries combined with decrease in number of blood donors. Restraints: Lower shelf-life and instability of artificial blood, Adverse effects associated with artificial blood substitutes, Stringent regulatory guidelines for product approval.

Artificial Blood Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 3,537.5 million

Market Size in 2031

US$ 7,771.5 million

Market CAGR

11.9%

By Product Type

  • Hemoglobin-Based Oxygen Carriers
  • Perflurocarbon-Based Products
  • Recombinant Factors
  • Synthetic Platelets
  • Plasma Expanders
  • Others

By Application

  • Traumatic Injuries
  • Blood Disorders
  • Anemia
  • Surgeries
  • Others

By Distribution Channel

  • Hospitals
  • Clinics
  • Blood Banks

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The artificial blood market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  •  The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The artificial blood market size was valued at US$ 3,537.5 million in 2024 and is expected to reach US$ 7,771.5 million by 2031, growing at a significant CAGR of 11.90% from 2025-2031

Alpha Therapeutic Corp, FluorO2 Therapeutics, Plasticell Limited

North America is the fastest-growing region in the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Artificial Blood Market Introduction 
2.1.Global Artificial Blood Market  - Taxonomy
2.2.Global Artificial Blood Market  - Definitions
2.2.1.Product Type 
2.2.2.Application
2.2.3.Distribution Channel
2.2.4.Region
3.Global Artificial Blood Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Artificial Blood Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Artificial Blood Market  By Product Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Hemoglobin-Based Oxygen Carriers
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Perflurocarbon-Based Products
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Recombinant Factors
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Synthetic Platelets
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Plasma Expanders
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Global Artificial Blood Market  By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Traumatic Injuries
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Blood Disorders
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Anemia
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Surgeries
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Artificial Blood Market  By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Blood Banks
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Artificial Blood Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Artificial Blood Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Product Type  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hemoglobin-Based Oxygen Carriers
9.1.2.Perflurocarbon-Based Products
9.1.3.Recombinant Factors
9.1.4.Synthetic Platelets
9.1.5.Plasma Expanders
9.1.6.Others
9.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Traumatic Injuries
9.2.2.Blood Disorders
9.2.3.Anemia
9.2.4.Surgeries
9.2.5.Others
9.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Blood Banks
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Artificial Blood Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hemoglobin-Based Oxygen Carriers
10.1.2.Perflurocarbon-Based Products
10.1.3.Recombinant Factors
10.1.4.Synthetic Platelets
10.1.5.Plasma Expanders
10.1.6.Others
10.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Traumatic Injuries
10.2.2.Blood Disorders
10.2.3.Anemia
10.2.4.Surgeries
10.2.5.Others
10.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Blood Banks
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Artificial Blood Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hemoglobin-Based Oxygen Carriers
11.1.2.Perflurocarbon-Based Products
11.1.3.Recombinant Factors
11.1.4.Synthetic Platelets
11.1.5.Plasma Expanders
11.1.6.Others
11.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Traumatic Injuries
11.2.2.Blood Disorders
11.2.3.Anemia
11.2.4.Surgeries
11.2.5.Others
11.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Blood Banks
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Artificial Blood Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hemoglobin-Based Oxygen Carriers
12.1.2.Perflurocarbon-Based Products
12.1.3.Recombinant Factors
12.1.4.Synthetic Platelets
12.1.5.Plasma Expanders
12.1.6.Others
12.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Traumatic Injuries
12.2.2.Blood Disorders
12.2.3.Anemia
12.2.4.Surgeries
12.2.5.Others
12.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Blood Banks
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Artificial Blood Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Hemoglobin-Based Oxygen Carriers
13.1.2.Perflurocarbon-Based Products
13.1.3.Recombinant Factors
13.1.4.Synthetic Platelets
13.1.5.Plasma Expanders
13.1.6.Others
13.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Traumatic Injuries
13.2.2.Blood Disorders
13.2.3.Anemia
13.2.4.Surgeries
13.2.5.Others
13.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Blood Banks
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Alpha Therapeutic Corp (U.S.)
14.2.2.FluorO2 Therapeutics (U.S.)
14.2.3.Plasticell Limited (U.K.)
14.2.4.B. Braun Melsungen
14.2.5.Cook Medical Incorporated
14.2.6.Becton, Dickinson and Company
14.2.7.Terumo Medical Corporation
14.2.8.Medtronic
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Alpha Therapeutic Corp (U.S.)
  • FluorO2 Therapeutics (U.S.)
  • Plasticell Limited (U.K.)
  • B. Braun Melsungen
  • Cook Medical Incorporated
  • Becton, Dickinson and Company
  • Terumo Medical Corporation
  • Medtronic

Related Industry Reports

Cancer Tumour Profiling Market

Patient Handling Equipment Market

Malaysia Skin Tightening Market

Malaysia Skin Resurfacing Market